Ruben Bender

Title: The Innovations of Ruben Bender

Introduction

Ruben Bender is an accomplished inventor based in Frankfurt-am-Main, Germany. He has made significant contributions to the field of biotechnology, particularly in the development of retroviral vectors for therapeutic applications. His innovative work has the potential to impact gene therapy and immune modulation.

Latest Patents

Ruben Bender holds a patent for a pseudotyped retrovirus-like particle or retroviral vector that incorporates engineered envelope glycoproteins derived from the Paramyxoviridae family. This invention is designed to selectively modulate the activity of specific immune cells, making it particularly useful for gene therapy, immune therapy, and vaccination. The patent is titled "Nipah virus envelope glycoprotein pseudotyped lentivirus" and represents a significant advancement in targeted therapeutic strategies.

Career Highlights

Throughout his career, Ruben has worked with prestigious institutions such as École Normale Supérieure de Lyon and the Centre National de la Recherche Scientifique. His experience in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Ruben has collaborated with notable colleagues, including Caroline Costa Fejoz and Els Verhoeyen. These partnerships have enriched his research and expanded the impact of his innovations.

Conclusion

Ruben Bender's work exemplifies the intersection of innovation and biotechnology. His contributions to the development of targeted therapeutic vectors highlight the potential for advancements in gene therapy and immune modulation.